|
시장보고서
상품코드
2024654
안전침 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)Safety Needles Market Report by Product, Application, End User, and Region 2026-2034 |
||||||
세계의 안전침 시장 규모는 2025년에 33억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 67억 달러에 달하며, 2026-2034년에 CAGR 7.89%로 성장할 것으로 예측하고 있습니다.
안전침은 약물 투여, 체액 채취, 의료 서비스 제공에 따른 침 찔림 사고 및 감염 확산 방지를 위해 사용됩니다. 이는 의료진과 환자를 혈액 매개 병원체 및 유해한 약물에 노출되지 않도록 보호합니다. 널리 사용되는 안전 바늘에는 생검 바늘, 후버 바늘, 캐뉼라, 펜 바늘, 봉합사 바늘, 봉합사 바늘, 피하 주사 바늘, 미세 흡입 바늘, 정맥 내(IV) 카테터, 채혈 바늘, 동정맥(AV) 누공, 척수 마취 및 경막 외 마취 바늘 등이 있습니다. 최근에는 인슐린 주사에 있으며, 다양한 이점을 제공하기 위해 안전 기능이 내장된 자동 펜침이 도입되고 있습니다.
안전침 시장 동향:
주사는 B형, D형, C형 간염, 인체면역결핍바이러스(HIV) 등 혈액 매개 질환의 주요 감염원으로 알려져 있습니다. 그 결과, 많은 국가의 보건 기관에서 안전한 주사제 사용에 관한 법률을 시행하고 있으며, 이는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 안전침은 의인성 감염 발생률을 낮추고 비용 절감에 기여합니다. 또한 신종 코로나바이러스 감염증(COVID-19) 백신 접종 시에는 혈액 매개 바이러스 감염 위험을 예방하고, 바늘에 찔리는 사고로부터 환자를 보호하기 위해 사용되고 있습니다. 이와 더불어, 만성질환의 유병률 증가와 프리필드 시린지와 관련된 위험에 대한 인식이 높아짐에 따라 전 세계에서 프리필드 시린지의 채택이 증가하고 있으며, 이는 시장을 주도하고 있습니다. 또한 많은 의료 관련 기업이 기존 주사기나 프리필드 시린지에 부착할 수 있는 바늘용 안전장치를 도입하고 있습니다. 또한 많은 국가의 규제 당국이 시행하고 있는 바늘 폐기 관련 조치도 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 미국 블루밍턴시에서는 공공 공원에 날카로운 물건 수거 용기를 설치하고 사용한 주사기 증가에 대처하기 위한 프로그램을 시작했습니다.
이 보고서에서 답변하는 주요 질문
- 세계 안전침 시장은 지금까지 어떤 추세를 보였으며, 향후 수년간 어떻게 변화하는가?
- COVID-19는 세계 안전침 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 제품별 시장 현황은?
- 용도별 시장 현황은?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 이 산업의 밸류체인에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계 안전침 시장의 구조는 어떻게 되어 있으며, 주요 기업은 어디인가?
- 업계의 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 안전침 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porters Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.05.18The global safety needles market size reached USD 3.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2034, exhibiting a growth rate (CAGR) of 7.89% during 2026-2034.
Safety needles are used to deliver drugs, collect fluids from the body, and prevent the spread of needlestick injuries or infections associated with healthcare provision. They protect healthcare workers and patients from bloodborne pathogens and hazardous drug exposure. Some of the widely available safety needles are biopsy, Huber, cannula, pen, suture, prefilled, hypodermic, fine aspirating, intravenous (IV) catheter, blood collection , arteriovenous (AV) fistula, and spinal anesthesia and epidural. Nowadays, automated pen needles with built-in safety features are being introduced to provide various benefits in insulin injection.
SAFETY NEEDLES MARKET TRENDS:
Injections are considered a main source of infection in transmitting bloodborne diseases, such as Hepatitis B, D, and C and Human Immunodeficiency Virus (HIV). As a result, health agencies of several countries are implementing laws for safe injection practices, which represents one of the major factors impelling the growth of the market. Safety needles help reduce the incidences of iatrogenic infection and save costs. In addition, they are used to prevent the transmission risk of bloodborne viruses and protect patients from needlestick injuries while administering coronavirus disease (COVID-19) vaccines. Apart from this, due to the growing prevalence of chronic diseases and awareness about the risk associated with filled syringes, there is a rise in the adoption of prefilled syringes across the globe, which, in turn, is driving the market. Moreover, several health firms are introducing needle-based safety devices that can be attached to a conventional or prefilled syringe. Furthermore, initiatives undertaken by governing agencies of numerous countries for needle disposal are projected to aid the market growth. For instance, a program was launched in the City of Bloomington (United States) to install sharps containers in public parks and address the increasing number of used syringes.
KEY MARKET SEGMENTATION:
Breakup by Product:
- Active Safety Needles
- Passive Safety Needles
- Others
Breakup by Application:
- Drug Delivery
- Sample Collection
- Injection
Breakup by End User:
- Hospitals and Ambulatory Surgery Centers
- Diabetic Patients
- Family Practice
- Psychiatry
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Johnson & Johnson, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Smiths Group plc, Terumo Corporation and Vygon.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global safety needles market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global safety needles market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global safety needles market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Safety Needles Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Active Safety Needles
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Passive Safety Needles
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Drug Delivery
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Sample Collection
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Injection
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Ambulatory Surgery Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diabetic Patients
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Family Practice
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Psychiatry
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 B. Braun Melsungen AG
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Becton Dickinson and Company
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Boston Scientific Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Johnson & Johnson
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Nipro Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Novo Nordisk A/S
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Retractable Technologies Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Smiths Group plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Terumo Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Vygon
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.1 B. Braun Melsungen AG
